Japan Heart Foundation

• NCT00294567

  Collaborator, Phase 4, Completed, 199 people, Feb 22, 2006

• NCT00285519

  Phase 4, Completed, 600 people, Feb 2, 2006

• NCT00265239

  Collaborator, Phase 4, Completed, 104 people, Dec 14, 2005

• Japanese Primary Prevention Project With Aspirin

  Collaborator, Phase 4, Status unknown, 10,000 people, Sep 26, 2005

• NCT00212004

  Collaborator, Phase 4, Terminated, 630 people, Sep 21, 2005

• NCT00139386

  Collaborator, Phase 4, Completed, 1,119 people, Aug 31, 2005

• NCT00134160

  Collaborator, Phase 4, Completed, 1,000 people, Aug 24, 2005

Sources: clinicaltrials.gov

• Association Between Long-Term Blood Pressure Patterns and Onset of Stroke: A Nested Case-Control Study of a Randomized Clinical Trial

  Oct 1, 2026

• Comparative Prognostic Performance of BMI- and Height-Indexed Muscle Mass in Older Patients With Heart Failure: Insights From FRAGILE-HF

  Sep 30, 2026

• Prognostic utility of the Global Leadership Initiative on Sarcopenia model in older patients with heart failure: post hoc analysis of the FRAGILE-HF study

  Sep 8, 2026

• Multicellular Cross Talk and Therapeutic Vaccines in Heart Failure

  Apr 29, 2026

• Prognostic value of GLIM criteria with and without inflammation assessment in older patients with heart failure: FRAGILE-HF cohort

  Mar 17, 2026

• Association of Muscle-specific Strength With Impaired Physical Function and Prognosis in Heart Failure: A Comparison With Muscle Strength

  Mar 17, 2026

• Tet2-driven clonal hematopoiesis drives aortic aneurysm via macrophage-to-osteoclast-like differentiation

  N/A, Feb 25, 2026

• Comparative prognostic value of three frailty-assessment tools in older patients with heart failure: post hoc analysis of the FRAGILE-HF cohort

  Feb 1, 2026

• Fat Mass and Cause-Specific Death in Older Patients with Heart Failure

  Dec 20, 2025

• Six-item screener for cognitive and prognostic assessment in heart failure: A comparison with the mini-cog

  Nov 28, 2025

• C-reactive protein-to-albumin ratio as a marker of frailty, impaired physical function, and mortality in older adults with heart failure

  Oct 10, 2025

• Prognostic importance of the reason for six-minute walk test interruption in hospitalized older patients with heart failure

  Sep 8, 2025

• Association of pre-admission exercise habit with post-discharge outcomes for older patients with heart failure

  Aug 25, 2025

• Current findings and challenges on frailty, sarcopenia, and cachexia in older patients with heart failure: insights from the FRAGILE-HF study

  May 28, 2025

• Sarcopenia in heart failure: Comparison of prognostic value between the Asian working Group for Sarcopenia 2014 and 2019 criteria

  May 6, 2025

• Association of Cardiovascular-Kidney-Metabolic Overlap with Physical Function and Prognosis in Older Patients with Heart Failure: A Post-hoc Analysis of the FRAGILE-HF and SONIC-HF

  May 6, 2025

• HINT1 suppression protects against age-related cardiac dysfunction by enhancing mitochondrial biogenesis

  Feb 3, 2025

• Comparison between DSQIID total / sub-item scores and plasma p-tau elevation in adults with Down's syndrome

  Dec 9, 2024

• Prognostic Value of Sarcopenia Definitions and Outcomes Consortium Criteria in Older Patients with Heart Failure

  Nov 12, 2024

• Prevalence and Prognostic Value of Cachexia Diagnosed by New Definition for Asian People in Older Patients With Heart Failure

  Nov 5, 2024

Sources: api.crossref.org, openalex.org